Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Gevorkyan, H."'
Autor:
Han K; Department of Clinical Pharmacology, Modeling & Simulation, GSK , Collegeville, Pennsylvania, USA., Gevorkyan H; California Clinical Trials Medical Group in affiliation with PAREXEL , Glendale, California, USA., Sadik Shaik J; Department of Clinical Pharmacology & Pharmacometrics, Janssen Research & Development , Spring House, Pennsylvania, USA., Crauwels H; Department of Clinical Pharmacology, Janssen Research & Development , Beerse, Belgium., Leemereise C; GSK , Amersfoort, the Netherlands., Bontempo G; ViiV Healthcare , Durham, North Carolina, USA., Win B; GSK , Stevenage, United Kingdom., Chounta V; ViiV Healthcare , Brentford, United Kingdom., Seal C; GSK , Collegeville, Pennsylvania, USA., DeMoor R; GSK , Collegeville, Pennsylvania, USA., D'Amico R; ViiV Healthcare , Durham, North Carolina, USA., Spreen WR; ViiV Healthcare , Durham, North Carolina, USA., Ford SL; Department of Clinical Pharmacology, Modeling & Simulation, GSK , Durham, North Carolina, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0078123. Date of Electronic Publication: 2023 Dec 01.
Autor:
Yamakawa N; Eisai Co., Ltd., Bunkyo-ku, Tokyo, Japan., Tago F; Eisai Co., Ltd., Bunkyo-ku, Tokyo, Japan., Nakai K; Eisai Co., Ltd., Bunkyo-ku, Tokyo, Japan., Kitahara Y; Eisai Inc., Nutley, New Jersey, USA., Ikari S; Eisai Co., Ltd., Bunkyo-ku, Tokyo, Japan., Hojo S; Eisai Co., Ltd., Bunkyo-ku, Tokyo, Japan., Hall N; Eisai Inc., Nutley, New Jersey, USA., Aluri J; Eisai Inc., Nutley, New Jersey, USA., Hussein Z; Eisai Ltd., Hatfield, UK., Gevorkyan H; California Clinical Trials Medical Group in affiliation with PAREXEL, Glendale, Glendale, California, USA., Maruyama T; Clinical Research Promotion Center, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan., Ishizaka S; Eisai Inc./Eisai Center for Genetics Guided Dementia Discovery, Cambridge, Massachusetts, USA., Yagi T; Eisai Inc., Nutley, New Jersey, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Apr; Vol. 12 (4), pp. 363-375. Date of Electronic Publication: 2022 Oct 11.
Autor:
Yin W; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Mamashli F; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.; Signal Insights, LLC, Cambridge, MA, USA., Buhl DL; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Khudyakov P; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Volfson D; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Martenyi F; Prothena Biosciences, South San Francisco, CA, USA., Gevorkyan H; California Clinical Trials Medical Group, in affiliation with Parexel International, Glendale, CA, USA., Rosen L; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Simen AA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Feb; Vol. 88 (2), pp. 600-612. Date of Electronic Publication: 2021 Jul 31.
Autor:
Kumar, Mokshada1 (AUTHOR) mokshada@buffalo.edu, Lanke, Sravani1 (AUTHOR) sravanil@buffalo.edu, Yadav, Alka1 (AUTHOR) alkachan@buffalo.edu, Ette, Mfonabasi1 (AUTHOR) mfonabas@buffalo.edu, Mager, Donald E.1,2 (AUTHOR) dmager@buffalo.edu, Shah, Dhaval K.1 (AUTHOR) dshah4@buffalo.edu
Publikováno v:
Antibodies (2073-4468). Sep2024, Vol. 13 Issue 3, p54. 25p.
Autor:
Watanabe M; Taisho Pharmaceutical R&D Inc., NJ, USA., Marcy B; Taisho Pharmaceutical R&D Inc., NJ, USA., Kinoshita K; Taisho Pharmaceutical Co., Ltd., Tokyo, Japan., Fukasawa M; Taisho Pharmaceutical Co., Ltd., Tokyo, Japan., Hikichi H; Taisho Pharmaceutical Co., Ltd., Tokyo, Japan., Chaki S; Taisho Pharmaceutical Co., Ltd., Tokyo, Japan., Okuyama S; Taisho Pharmaceutical Co., Ltd., Tokyo, Japan., Gevorkyan H; California Clinical Trials Medical Group, CA, USA., Yoshida S; Taisho Pharmaceutical Co., Ltd., Tokyo, Japan.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2020 Nov; Vol. 86 (11), pp. 2286-2301. Date of Electronic Publication: 2020 Jun 10.
Autor:
Ackert J; Clinical Research and Development, GlaxoSmithKline, Collegeville, PA, USA., Mohamed K; Quantitative Sciences, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Slakter JS; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., El-Harazi S; Lugene Eye Institute, Glendale, CA, USA., Berni A; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK., Gevorkyan H; California Clinical Trials Medical Group in affiliation with Parexel International, Glendale, CA, USA., Hardaker E; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Hussaini A; PAREXEL, Harbor Hospital, Baltimore, Baltimore, MD, USA., Jones SW; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Koh GCKW; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK., Patel J; Clinical Data Management, GlaxoSmithKline Research and Development, Collegeville, PA, USA., Rasmussen S; IQVIA, Overland Park, KS, USA., Kelly DS; Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Collegeville, PA, USA., Barañano DE; Retina Specialists, Baltimore, MD, USA., Thompson JT; Retina Specialists, Baltimore, MD, USA., Warren KA; IQVIA, Overland Park, KS, USA., Sergott RC; Neuro-Ophthalmology Service, Wills Eye Hospital, Philadelphia, PA, USA., Tonkyn J; GSK Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Wolstenholme A; GlaxoSmithKline, Upper Providence, Collegeville, PA, USA., Coleman H; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., Yuan A; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., Duparc S; Research and Development, Medicines for Malaria Venture, Geneva, Switzerland., Green JA; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK. justin.a.green@gsk.com.
Publikováno v:
Drug safety [Drug Saf] 2019 Sep; Vol. 42 (9), pp. 1103-1114.
Autor:
Baverel P; MedImmune, Cambridge, UK. Electronic address: baverelp@medimmune.com., She D; MedImmune, Gaithersburg, MD, USA., Piper E; AstraZeneca, Cambridge, UK., Ueda S; AstraZeneca K.K., Osaka, Japan., Yoshioka T; AstraZeneca K.K., Osaka, Japan., Faggioni R; MedImmune, Mountain View, CA, USA., Gevorkyan H; California Clinical Trials Medical Group, Inc., Glendale, CA, USA.
Publikováno v:
Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2018 Jun; Vol. 33 (3), pp. 150-158. Date of Electronic Publication: 2017 Dec 12.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tsai M; Takeda Development Center Americas, Inc., One Takeda Parkway, Deerfield, IL, 60015, USA., Chrones L; Takeda Development Center Americas, Inc., One Takeda Parkway, Deerfield, IL, 60015, USA., Xie J; Takeda Development Center Americas, Inc., One Takeda Parkway, Deerfield, IL, 60015, USA., Gevorkyan H; California Clinical Trials Medical Group, Glendale, CA, USA., Macek TA; Takeda Development Center Americas, Inc., One Takeda Parkway, Deerfield, IL, 60015, USA. tom.macek@takeda.com.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2016 Oct; Vol. 233 (21-22), pp. 3787-3795. Date of Electronic Publication: 2016 Aug 30.
Autor:
Langenickel TH; Translational Medicine, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Tsubouchi C; Translational Medicine, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Ayalasomayajula S; Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, East Hanover, New Jersey, USA., Pal P; Biostatistical Sciences, Integrated Development Functions and Regions, Novartis Healthcare Pvt Ltd, Hyderabad, India., Valentin MA; Translational Medicine, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Hinder M; Translational Medicine, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Jhee S; PAREXEL International, Glendale, California, USA., Gevorkyan H; California Clinical Trials Medical Group in Affiliation with PAREXEL International, Glendale, California, USA., Rajman I; Translational Medicine, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 May; Vol. 81 (5), pp. 878-90. Date of Electronic Publication: 2016 Mar 08.